The Myc pathway (predicted with 0.795 AUC) acts as a key regulator of cell growth and proliferation, which has been linked to the basal-like breast cancer32,33, and can serve as a target for this aggressive subtype in breast cancer. This evidence concerns the gene MYC and breast cancer.